Skip to main content

Antihistamines and Itch

  • Chapter

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 226))

Abstract

Histamine is one of the best-characterized pruritogens in humans. It is known to play a role in pruritus associated with urticaria as well as ocular and nasal allergic reactions. Histamine mediates its effect via four receptors. Antihistamines that block the activation of the histamine H1 receptor, H1R, have been shown to be effective therapeutics for the treatment of pruritus associated with urticaria, allergic rhinitis, and allergic conjunctivitis. However, their efficacy in other pruritic diseases such as atopic dermatitis and psoriasis is limited. The other histamine receptors may also play a role in pruritus, with the exception of the histamine H2 receptor, H2R. Preclinical evidence indicates that local antagonism of the histamine H3 receptor, H3R, can induce scratching perhaps via blocking inhibitory neuronal signals. The histamine H4 receptor, H4R, has received a significant amount of attention as to its role in mediating pruritic signals. Indeed, it has now been shown that a selective H4R antagonist can inhibit histamine-induced itch in humans. This clinical result, in conjunction with efficacy in various preclinical pruritus models, points to the therapeutic potential of H4R antagonists for the treatment of pruritus not controlled by antihistamines that target the H1R.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abelson MB (1998) Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann Allergy Asthma Immunol 81:211–218

    CAS  PubMed  Google Scholar 

  • Abelson MB, Kaplan AP (2002) A randomized, double-blind, placebo-controlled comparison of emedastine 0.05 % ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model. Clin Ther 24:445–456

    CAS  PubMed  Google Scholar 

  • Abelson MB, Lanier RQ (1999) The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model. Acta Ophthalmol Scand Suppl 228:53–56

    PubMed  Google Scholar 

  • Abelson MB, Smith LM (1988) Levocabastine. Evaluation in the histamine and compound 48/80 models of ocular allergy in humans. Ophthalmology 95:1494–1497

    CAS  PubMed  Google Scholar 

  • Abelson MB, Welch DL (2000) An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1 %) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model. Acta Ophthalmol Scand Suppl 230:60–63

    PubMed  Google Scholar 

  • Abelson MB, Allansmith MR, Friedlaender MH (1980) Effects of topically applied occular decongestant and antihistamine. Am J Ophthalmol 90:254–257

    CAS  PubMed  Google Scholar 

  • Abelson MB, George MA, Smith LM (1995) Evaluation of 0.05 % levocabastine versus 4 % sodium cromolyn in the allergen challenge model. Ophthalmology 102:310–316

    CAS  PubMed  Google Scholar 

  • Abelson MB, Torkildsen GL, Williams JI, Gow JA, Gomes PJ, McNamara TR (2009) Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0 % and 1.5 % in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Clin Ther 31:1908–1921

    CAS  PubMed  Google Scholar 

  • Ahern K, Gilmore ES, Poligone B (2012) Pruritus in cutaneous T-cell lymphoma: a review. J Am Acad Dermatol 67:760–768

    PubMed Central  PubMed  Google Scholar 

  • Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung Donald YM, Lipozencic J, Luger Thomas A, Muraro A, Novak N, Platts-Mills Thomas AE, Rosenwasser L, Scheynius A, Simons FER, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 118:152–169

    PubMed  Google Scholar 

  • Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD (2008) Structure-activity studies on a series of 2-aminopyrimidine-containing histamine H4 receptor ligands. J Med Chem 51:6571–6580

    CAS  PubMed  Google Scholar 

  • Amano T, Takeda T, Yano H, Tamura T (2007) Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice. Br J Dermatol 156:906–912

    CAS  PubMed  Google Scholar 

  • Andrew D, Craig AD (2001) Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 4:72–77

    CAS  PubMed  Google Scholar 

  • Anolik R (2008) Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 100:264–271

    CAS  PubMed  Google Scholar 

  • Appl H, Holzammer T, Dove S, Haen E, Strasser A, Seifert R (2012) Interactions of recombinant human histamine H1, H2, H3, and H4 receptors with 34 antidepressants and antipsychotics. Naunyn Schmiedeberg’s Arch Pharmacol 385:145–170

    CAS  Google Scholar 

  • Arnulf I (2009) Results of clinical trials of tiprolisant in narcolepsy and Parkinson’s disease. In: 22nd ECNP congress p S.19.05, Istanbul, Turkey

    Google Scholar 

  • Arrang JM, Garbarg M, Schwartz JC (1983) Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832–837

    CAS  PubMed  Google Scholar 

  • Arrang JM, Garbarg M, Tam TQ, My DTT, Yeramian E, Schwartz JC (1985) Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 111:73–84

    CAS  PubMed  Google Scholar 

  • Ash ASF, Schild JO (1966) Receptors mediating some action of histamine. Br J Pharmacol Chemother 27:427–439

    PubMed Central  CAS  PubMed  Google Scholar 

  • Ashford CA, Heller H, Smart GA (1949) Effect of antihistamine substances on gastric secretion in man. Br J Pharmacol Chemother 4:157–161

    PubMed Central  CAS  PubMed  Google Scholar 

  • Baeumer W, Stahl J, Sander K, Petersen LJ, Paps J, Stark H, Kietzmann M, Olivry T (2011) Lack of preventing effect of systemically and topically administered histamine H1 or H4 receptor antagonists in a dog model of acute atopic dermatitis. Exp Dermatol 20:577–581

    CAS  Google Scholar 

  • Bakker RA, Schoonus SBJ, Smit MJ, Timmerman H, Leurs R (2001) Histamine H1-receptor activation of nuclear factor-kB: roles for Gbg- and Gaq/11-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60:1133–1142

    CAS  PubMed  Google Scholar 

  • Barchuk WT, Salapatek AM, Ge T, D’Angelo P, Liu X (2013) A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion. J Allergy Clin Immunol 132:838–846.e836

    CAS  PubMed  Google Scholar 

  • Barger G, Dale HH (1910) 4-β-Aminoethylglyoxaline (β-Aminazolylethylamine) and the other active principles of ergot. J Chem Soc Trans 97:2592–2595

    CAS  Google Scholar 

  • Bäumer W, Wendorff S, Gutzmer R, Werfel T, Dijkstra D, Chazot P, Stark H, Kietzmann M (2008) Histamine H4 receptors modulate dendritic cell migration through skin—immunomodulatory role of histamine. Allergy 63:1387–1394

    PubMed  Google Scholar 

  • Beermann S, Seifert R, Neumann D (2012) Commercially available antibodies against human and murine histamine H4-receptor lack specificity. Naunyn Schmiedeberg's Arch Pharmacol 385:125–135

    CAS  Google Scholar 

  • Bell JK, McQueen DS, Rees JL (2004) Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice. Br J Pharmacol 142:374–380

    PubMed Central  CAS  PubMed  Google Scholar 

  • Benninger M, Farrar JR, Blaiss M, Chipps B, Ferguson B, Krouse J, Marple B, Storms W, Kaliner M (2010) Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol 104:13–29

    PubMed  Google Scholar 

  • Bergasa NV, Jones EA (1991) Management of the pruritus of cholestasis: potential role of opiate antagonists. Am J Gastroenterol 86:1404–1412

    CAS  PubMed  Google Scholar 

  • Berger WE, Schenkel EJ, Mansfield LE (2002) Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy Asthma Immunol 89:485–491

    CAS  PubMed  Google Scholar 

  • Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J (1997) Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 79:443–448

    CAS  PubMed  Google Scholar 

  • Best CH, Dale HH, Dudley HW, Thorpe WV (1927) The nature of the vaso-dilator constituents of certain tissue extracts. J Physiol 62:397–417

    PubMed Central  CAS  PubMed  Google Scholar 

  • Bickford RG (1937) Experiments relating to the itch sensation, Its peripheral mechanism, and central pathways. Clin Sci 3:377–386

    Google Scholar 

  • Bielory L, Lien KW, Bigelsen S (2005) Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs 65:215–228

    CAS  PubMed  Google Scholar 

  • Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM (1972) Definition and antagonism of histamine H2-receptors. Nature 236:385–390

    CAS  PubMed  Google Scholar 

  • Bonadonna P, Lombardi C, Senna G, Canonica GW, Passalacqua G, Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL, Tharp MD, Treger C, Soter N (2003) Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol 49:714–716

    PubMed  Google Scholar 

  • Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS (2009) Efficacy of olopatadine HCI 0.1 %, ketotifen fumarate 0.025 %, epinastine HCI 0.05 %, emedastine 0.05 % and fluorometholone acetate 0.1 % ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Acta Ophthalmol 87:549–554

    CAS  PubMed  Google Scholar 

  • Bovet D, Staub AM (1937) Protective action of some phenolic ethers in histamine intoxication. C R Seances Soc Biol Fil 124:547–549

    CAS  Google Scholar 

  • Breneman DL (1996) Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 30:1075–1079

    CAS  PubMed  Google Scholar 

  • Breunig E, Michel K, Zeller F, Seidl S, von Weyhern CWH, Schemann M (2007) Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol (Oxford, UK) 583:731–742

    CAS  Google Scholar 

  • Brody I (1984) Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris. J Investig Dermatol 82:460–464

    CAS  PubMed  Google Scholar 

  • Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P (1996) Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 51:320–325

    CAS  PubMed  Google Scholar 

  • Buckland KF, Williams TJ, Conroy DM (2003) Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. Br J Pharmacol 140:1117–1127

    PubMed Central  CAS  PubMed  Google Scholar 

  • Buddenkotte J, Maurer M, Steinhoff M (2010) Histamine and antihistamines in atopic dermatitis. Adv Exp Med Biol 709:73–80

    CAS  PubMed  Google Scholar 

  • Carr WW, Nayak AS, Ratner PH, Gow JA, McNamara TR, Williams JI (2013) Efficacy of bepotastine besilate ophthalmic solution 1.5 % for seasonal allergic conjunctivitis: a randomized, placebo-controlled, natural exposure, clinical trial. Allergy Asthma Proc 34:247–254

    CAS  PubMed  Google Scholar 

  • Celice J, Perrault M, Durel P (1942) Utilisation clinique des antihistaminiques de synthese. Bull Mem Soc Med Hop Paris 21–22:284–288

    Google Scholar 

  • Chang RSL, Vihn TT, Snyder SH (1979) Heterogeneity of histamine H1-receptors: species variations in [3H]mepyramine binding of brain membranes. J Neurochem 32:1653–1663

    CAS  PubMed  Google Scholar 

  • Ciprandi G, Buscaglia S, Catrullo A, Pesce G, Fiorino N, Montagna P, Bagnasco M, Canonica GW (1997) Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity. Clin Exp Allergy 27:182–191

    CAS  PubMed  Google Scholar 

  • Clough GF, Boutsiouki P, Church MK (2001) Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy 56:985–988

    CAS  PubMed  Google Scholar 

  • Coge F, Guenin S-P, Audinot V, Renouard-Try A, Beauverger P, Macia C, Ouvry C, Nagel N, Rique H, Boutin JA, Galizzi J-P (2001) Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J 355:279–288

    PubMed Central  CAS  PubMed  Google Scholar 

  • Connelly WM, Shenton FC, Lethbridge N, Leurs R, Waldvogel HJ, Faull RLM, Lees G, Chazot PL (2009) The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 157:55–63

    PubMed Central  CAS  PubMed  Google Scholar 

  • Cormia FE, Kuykendall V (1954) Experimental histamine pruritus. III. Influence of drugs on the itch threshold. AMA Arch Derm Syphilol 69:206–218

    CAS  PubMed  Google Scholar 

  • Coruzzi G, Adami M, Guaita E, de Esch IJP, Leurs R (2007) Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol 563:240–244

    CAS  PubMed  Google Scholar 

  • Coulie PJ, Ghys L, Rihoux JP (1991) Histamine-induced wheal, flare, and pruritus: inhibition by cetirizine, terfenadine, and placebo. Drug Dev Res 23:269–274

    CAS  Google Scholar 

  • Cowart MD, Altenbach RJ, Liu H, Hsieh GC, Drizin I, Milicic I, Miller TR, Witte DG, Wishart N, Fix-Stenzel SR, McPherson MJ, Adair RM, Wetter JM, Bettencourt BM, Marsh KC, Sullivan JP, Honore P, Esbenshade TA, Brioni JD (2008) Rotationally constrained 2,4-Diamino-5,6-disubstituted pyrimidines: A new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 51:6547–6557

    CAS  PubMed  Google Scholar 

  • Cowden JM, Zhang M, Dunford PJ, Thurmond RL (2010) The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Investig Dermatol 130:1023–1033

    CAS  PubMed  Google Scholar 

  • Crampton HJ (2002) A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025 % ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model. Clin Ther 24:1800–1808

    CAS  PubMed  Google Scholar 

  • Crampton HJ (2003) Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial. Clin Ther 25:1975–1987

    CAS  PubMed  Google Scholar 

  • Curtis AC, Owens BB (1945) Beta dimethylaminoethyl benzhydryl ether hydrochloride (benadryl) in treatment of urticaria. Arch Derm Syphilol 52:239–242

    CAS  PubMed  Google Scholar 

  • D'Arienzo PA, Leonardi A, Bensch G (2002) Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05 % ophthalmic solution and ketotifen fumarate 0.025 % ophthalmic solution in the human conjunctival allergen challenge model. Clin Ther 24:409–416

    PubMed  Google Scholar 

  • Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, Schwaiger M, Ring J (2000) Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Investig Dermatol 115:1029–1033

    CAS  PubMed  Google Scholar 

  • Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler GJ Jr (2007) The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 27:10007–10014

    PubMed Central  CAS  PubMed  Google Scholar 

  • Davidson S, Zhang X, Khasabov SG, Simone DA, Giesler GJ Jr (2009) Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons. Nat Neurosci 12:544–546

    PubMed Central  CAS  PubMed  Google Scholar 

  • Davies MG, Greaves MW (1980) Sensory responses of human skin to synthetic histamine analogs and histamine. Br J Clin Pharmacol 9:461–465

    PubMed Central  CAS  PubMed  Google Scholar 

  • Davies MG, Marks R, Horton RJ, Storari FE (1979) The efficacy of histamine antagonists as antipruritics in experimentally induced pruritus. Arch Dermatol Res 266:117–120

    CAS  PubMed  Google Scholar 

  • De Backer MD, Gommeren W, Moereels H, Nobels G, Van Gompel P, Leysen JE, Luyten WHML (1993) Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. Biochem Biophys Res Commun 197:1601–1608

    PubMed  Google Scholar 

  • Decourt P (1942) Action de bases antagonistes de l'histamine sur quelques maladies liees a des reactions d'hypersensibilite. Bull Mem Soc Med Hop Paris 58:265–266

    Google Scholar 

  • Deml K-F, Beermann S, Neumann D, Strasser A, Seifert R (2009) Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor. Mol Pharmacol 76:1019–1030

    CAS  PubMed  Google Scholar 

  • Denham KJ, Boutsiouki P, Clough GF, Church MK (2003) Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Inflamm Res 52:424–427

    CAS  PubMed  Google Scholar 

  • Desmadryl G, Gaboyard-Niay S, Brugeaud A, Travo C, Broussy A, Saleur A, Dyhrfjeld-Johnsen J, Wersinger E, Chabbert C (2012) Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability. Br J Pharmacol 167:905–916

    PubMed Central  CAS  PubMed  Google Scholar 

  • Dijkstra D, Stark H, Chazot PL, Shenton FC, Leurs R, Werfel T, Gutzmer R (2008) Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Investig Dermatol 128:1696–1703

    CAS  PubMed  Google Scholar 

  • Discepola M, Deschenes J, Abelson M (1999) Comparison of the topical ocular antiallergic efficacy of emedastine 0.05 % ophthalmic solution to ketorolac 0.5 % ophthalmic solution in a clinical model of allergic conjunctivitis. Acta Ophthalmol Scand Suppl 228:43–46

    PubMed  Google Scholar 

  • Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, Weilke F, Ring J, Schwaiger M, Bartenstein P (2001) Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 92:295–305

    CAS  PubMed  Google Scholar 

  • Dubertret L, Murrieta Aguttes M, Tonet J (1999) Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. J Eur Acad Dermatol Venereol 12:16–24

    CAS  PubMed  Google Scholar 

  • Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL (2006) The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 176:7062–7070

    CAS  PubMed  Google Scholar 

  • Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL (2007) Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 119:176–183

    CAS  PubMed  Google Scholar 

  • Eglezos A, Lecci A, Santicioli P, Giuliani S, Tramontana M, Del Bianco E, Maggi CA (1992) Activation of capsaicin-sensitive primary afferents in the rat urinary bladder by compound 48/80: a direct action on sensory nerves? Arch Int Pharmacodyn Ther 315:96–109

    CAS  PubMed  Google Scholar 

  • Eppinger H (1913) Wien Med Wochenschr 23:1414

    Google Scholar 

  • Eriks JC, Van DGH, Timmerman H (1993) New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists. Mol Pharmacol 44:886–894

    CAS  PubMed  Google Scholar 

  • Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA (2003) Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects. J Pharmacol Exp Ther 305:887–896

    CAS  PubMed  Google Scholar 

  • Fedorowicz Z, van Zuuren EJ, Hu N (2012) Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev 3:CD008596

  • Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J (1999) A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 104:1071–1078

    CAS  PubMed  Google Scholar 

  • Fjellner B, Haegermark O (1981) Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol 61:245–250

    CAS  PubMed  Google Scholar 

  • Fjellner B, Hagermark O (1985) Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. Acta Derm Venereol 65:409–412

    CAS  PubMed  Google Scholar 

  • Francos GC, Kauh YC, Gittlen SD, Schulman ES, Besarab A, Goyal S, Burke JF Jr (1991) Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Int J Dermatol 30:884–889

    CAS  PubMed  Google Scholar 

  • Furue M, Terao H, Koga T (2001) Effects of Cetirizine and Epinastine on the skin response to histamine iontophoresis. J Dermatol Sci 25:59–63

    CAS  PubMed  Google Scholar 

  • Galeotti N, Sanna MD, Ghelardini C (2013) Pleiotropic effect of histamine H4 receptor modulation in the central nervous system. Neuropharmacology 71:141–147

    CAS  PubMed  Google Scholar 

  • Gallois-Bernos AC, Thurmond RL (2012) Alcaftadine, a new antihistamine with combined antagonist activity at histamine H1, H2, and H4 receptors. J Recept Ligand Channel Res 5:9–20

    CAS  Google Scholar 

  • Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, DelValle J, Yamada T (1991) Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 178:1386–1392

    CAS  PubMed  Google Scholar 

  • Gbahou F, Vincent L, Humbert-Claude M, Tardivel-Lacombe J, Chabret C, Arrang J-M (2006) Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives. Br J Pharmacol 147:744–754

    PubMed Central  CAS  PubMed  Google Scholar 

  • Gillard M, Van Der Perren C, Moguilevsky N, Massingham R, Chatelain P (2002) Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol 61:391–399

    CAS  PubMed  Google Scholar 

  • Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E (2007) Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Allergy 62:539–546

    CAS  PubMed  Google Scholar 

  • Gimenez-Arnau A, Izquierdo I, Maurer M (2009) The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 23:1088–1091

    CAS  PubMed  Google Scholar 

  • Glatzer F, Gschwandtner M, Ehling S, Rossbach K, Janik K, Klos A, Baeumer W, Kietzmann M, Werfel T, Gutzmer R (2013) Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor. J Allergy Clin Immunol 132:1358–1367

    CAS  PubMed  Google Scholar 

  • Govoni M, Bakker RA, van de Wetering I, Smit MJ, Menge WM, Timmerman H, Elz S, Schunack W, Leurs R (2003) Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists. J Med Chem 46:5812–5824

    CAS  PubMed  Google Scholar 

  • Graham DT, Goodell H, Wolff HG (1951) Neural mechanisms involved in itch, itchy skin, and tickle sensations. J Clin Investig 30:37–49

    PubMed Central  CAS  PubMed  Google Scholar 

  • Greaves MW (1995) Chronic urticaria. N Engl J Med 332:1767–1772

    CAS  PubMed  Google Scholar 

  • Greiner JV, Minno G (2003) A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. Clin Ther 25:1988–2005

    CAS  PubMed  Google Scholar 

  • Greiner JV, Edwards-Swanson K, Ingerman A (2011) Evaluation of alcaftadine 0.25 % ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1 %. Clin Ophthalmol 5:87–93

    PubMed Central  CAS  PubMed  Google Scholar 

  • Gschwandtner M, Mommert S, Koether B, Werfel T, Gutzmer R (2011a) The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Investig Dermatol 131:1668–1676

    CAS  PubMed  Google Scholar 

  • Gschwandtner M, Schaekel K, Werfel T, Gutzmer R (2011b) Histamine H4 receptor activation on human slan-dendritic cells down-regulates their pro-inflammatory capacity. Immunology 132:49–56

    PubMed Central  CAS  PubMed  Google Scholar 

  • Gutzmer R, Mommert S, Gschwandtner M, Zwingmann K, Stark H, Werfel T (2009) The histamine H4 receptor is functionally expressed on TH2 cells. J Allergy Clin Immunol 123:619–625

    CAS  PubMed  Google Scholar 

  • Hagermark O (1973) Influence of antihistamines, sedatives, and aspirin on experimental itch. Acta Derm Venereol 53:363–368

    CAS  PubMed  Google Scholar 

  • Hagermark O, Hokfelt T, Pernow B (1978) Flare and itch induced by substance P in human skin. J Investig Dermatol 71:233–235

    CAS  PubMed  Google Scholar 

  • Hagermark O, Strandberg K, Gronneberg R (1979) Effects of histamine receptor antagonists on histamine-induced responses in human skin. Acta Derm Venereol 59:297–300

    CAS  PubMed  Google Scholar 

  • Halpern BN (1942) Synthetic antihistamine substances. Arch Int Pharmacodyn Ther 68:339–408

    CAS  Google Scholar 

  • Han L, Ma C, Liu Q, Weng H-J, Cui Y, Tang Z, Kim Y, Nie H, Qu L, Patel KN, Li Z, McNeil B, He S, Guan Y, Xiao B, LaMotte RH, Dong X (2013) A subpopulation of nociceptors specifically linked to itch. Nat Neurosci 16:174–182

    PubMed Central  CAS  PubMed  Google Scholar 

  • Handwerker HO, Forster C, Kirchhoff C (1991) Discharge patterns of human C-fibers induced by itching and burning stimuli. J Neurophysiol 66:307–315

    CAS  PubMed  Google Scholar 

  • Harada M, Terai M, Maeno H (1983) Effect of a new potent H2-receptor antagonist 3[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric mucosal histamine-sensitive adenylate cyclase from guinea pig. Biochem Pharmacol 32:1635–1640

    CAS  PubMed  Google Scholar 

  • Havas TE, Cole P, Parker L, Oprysk D, Ayiomamitis A (1986) The effects of combined H1 and H2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation. J Allergy Clin Immunol 78:856–860

    CAS  PubMed  Google Scholar 

  • Herde L, Forster C, Strupf M, Handwerker HO (2007) Itch induced by a novel method leads to limbic deactivations a functional MRI study. J Neurophysiol 98:2347–2356

    PubMed  Google Scholar 

  • Herndon JH Jr (1975) Itching: the pathophysiology of pruritus. Int J Dermatol 14:465–484

    PubMed  Google Scholar 

  • Herring WJ, Wilens TE, Adler LA, Baranak C, Liu K, Snavely DB, Lines CR, Michelson D (2012) Randomized controlled study of the histamine h3 inverse agonist mk-0249 in adult attention-deficit/hyperactivity disorder. J Clin Psychiatry 73:e891–e898

    CAS  PubMed  Google Scholar 

  • Hilberg O (1995) Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy 50:683–688

    CAS  PubMed  Google Scholar 

  • Horak F, Berger UE, Menapace R, Toth J, Stubner PU, Marks B (1998) Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study. Arzneimittelforschung 48:379–384

    CAS  PubMed  Google Scholar 

  • Horsmanheimo L, Harvima IT, Harvima RJ, Brummer-Korvenkontio H, Francois G, Reunala T (1996) Histamine and leukotriene C4 release in cutaneous mosquito-bite reactions. J Allergy Clin Immunol 98:408–411

    CAS  PubMed  Google Scholar 

  • Hosogi M, Schmelz M, Miyachi Y, Ikoma A (2006) Bradykinin is a potent pruritogen in atopic dermatitis: A switch from pain to itch. Pain 126:16–23

    CAS  PubMed  Google Scholar 

  • Hossen MA, Sugimoto Y, Kayasuga R, Kamei C (2003) Involvement of histamine H3 receptors in scratching behavior in mast cell-deficient mice. Br J Dermatol 149:17–22

    CAS  PubMed  Google Scholar 

  • Hossen MA, Inoue T, Shinmei Y, Fujii Y, Watanabe T, Kamei C (2006) Role of substance P on histamine H3 antagonist-induced scratching behavior in mice. J Pharmacol Sci (Tokyo, Japan) 100:297–302

    CAS  Google Scholar 

  • Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J (1999) Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol 104:927–933

    CAS  PubMed  Google Scholar 

  • Hsieh JC, Hagermark O, Stahle-Backdahl M, Ericson K, Eriksson L, Stone-Elander S, Ingvar M (1994) Urge to scratch represented in the human cerebral cortex during itch. J Neurophysiol 72:3004–3008

    CAS  PubMed  Google Scholar 

  • Hsieh GC, Chandran P, Salyers AK, Pai M, Zhu CZ, Wensink EJ, Witte DG, Miller TR, Mikusa JP, Baker SJ, Wetter JM, Marsh KC, Hancock AA, Cowart MD, Esbenshade TA, Brioni JD, Honore P (2010) H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav 95:41–50

    CAS  PubMed  Google Scholar 

  • Iannone R, Palcza J, Renger JJ, Calder N, Cerchio K, Gottesdiener K, Hargreaves R, Dijk DJ, Boyle J, Murphy MG (2010) Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers. Clin Pharmacol Ther (NewYork, USA) 88:831–839

    CAS  Google Scholar 

  • Ikawa Y, Shiba K, Ohki E, Mutoh N, Suzuki M, Sato H, Ueno K (2008) Comparative study of histamine H4 receptor expression in human dermal fibroblasts. J Toxicol Sci 33:503–508

    CAS  PubMed  Google Scholar 

  • Ikoma A (2009) Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mechanisms and management of itch in atopic dermatitis. J Pharmacol Sci 110:265–269

    CAS  PubMed  Google Scholar 

  • Inocente C, Arnulf I, Bastuji H, Thibault-Stoll A, Raoux A, Reimao R, Lin J-S, Franco P (2012) Pitolisant, an inverse agonist of the histamine H3 receptor: An alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol 35:55–60

    CAS  PubMed  Google Scholar 

  • Johanek LM, Meyer RA, Hartke T, Hobelmann JG, Maine DN, LaMotte RH, Ringkamp M (2007) Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J Neurosci 27:7490–7497

    CAS  PubMed  Google Scholar 

  • Johanek LM, Meyer RA, Friedman RM, Greenquist KW, Shim B, Borzan J, Hartke T, LaMotte RH, Ringkamp M (2008) A role for polymodal C-fiber afferents in nonhistaminergic itch. J Neurosci 28:7659–7669

    PubMed Central  CAS  PubMed  Google Scholar 

  • Johnson HH Jr, DeOreo GA, Lascheid WP, Mitchell F (1960) Skin histamine levels in chronic atopic dermatitis. J Investig Dermatol 34:237–238

    CAS  PubMed  Google Scholar 

  • Juhlin L (1967) Localization and content of histamine in normal and diseased skin. Acta Derm Venereol 47:383–391

    CAS  PubMed  Google Scholar 

  • Juhlin L (2004) Inhibition of cold urticaria by desloratadine. J Dermatolog Treat 15:51–59

    CAS  PubMed  Google Scholar 

  • Kabashima K (2013) New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 70:3–11

    PubMed  Google Scholar 

  • Kameyoshi Y, Tanaka T, Mihara S, Takahagi S, Niimi N, Hide M (2007) Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol 157:803–804

    CAS  PubMed  Google Scholar 

  • Kamo A, Negi O, Tengara S, Kamata Y, Noguchi A, Ogawa H, Tominaga M, Takamori K (2014) Histamine H4 receptor antagonists ineffective against itch and skin inflammation in atopic dermatitis mouse model. J Investig Dermatol 134:546–548

    CAS  PubMed  Google Scholar 

  • Kaplan AP (2002) Chronic urticaria–new concepts regarding pathogenesis and treatment. Curr Allergy Asthma Rep 2:263–264

    PubMed  Google Scholar 

  • Kaplan AP, Horakova Z, Katz SI (1978) Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 61:350–354

    CAS  PubMed  Google Scholar 

  • Kaplan AP, Spector SL, Meeves S, Liao Y, Varghese ST, Georges G (2005) Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 94:662–669

    CAS  PubMed  Google Scholar 

  • Karppinen A, Petman L, Jekunen A, Kautiainen H, Vaalasti A, Reunala T (2000) Treatment of mosquito bites with ebastine: a field trial. Acta Derm Venereol 80:114–116

    CAS  PubMed  Google Scholar 

  • Karppinen A, Brummer-Korvenkontio H, Petman L, Kautiainen H, Herve J-P, Reunala T (2006) Levocetirizine for treatment of immediate and delayed mosquito bite reactions. Acta Derm Venereol 86:329–331

    CAS  PubMed  Google Scholar 

  • Kato M, Nishida A, Aga Y, Kita J, Kudo Y, Narita H, Endo T (1997) Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent bepotastine besilate. Arzneimittelforschung 47:1116–1124

    CAS  PubMed  Google Scholar 

  • Kavanagh GM, Sabroe RA, Greaves MW, Archer CB (1998) The intradermal effects of the H3 receptor agonist R α methylhistamine in human skin. Br J Dermatol 138:622–626

    CAS  PubMed  Google Scholar 

  • Khan DA (2008) Chronic urticaria: diagnosis and management. Allergy Asthma Proc 29:439–446

    CAS  PubMed  Google Scholar 

  • Kim K, Sussman G, Hebert J, Lumry W, Lutsky B, Gates D (2006) Desloratadine therapy for symptoms associated with perennial allergic rhinitis. Ann Allergy Asthma Immunol 96:460–465

    CAS  PubMed  Google Scholar 

  • Kirkegaard J, Secher C, Mygind N (1982) Effect of the H1 antihistamine chlorpheniramine maleate on histamine-induced symptoms in the human conjunctiva. Indirect evidence for nervous H1 receptors. Allergy 37:203–208

    CAS  PubMed  Google Scholar 

  • Kirkegaard J, Secher C, Borum P, Mygind N (1983) Inhibition of histamine-induced nasal symptoms by the H1 antihistamine chlorpheniramine maleate: demonstration of topical effect. Br J Dis Chest 77:113–122

    CAS  PubMed  Google Scholar 

  • Klein PA, Clark RAF (1999) An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 135:1522–1525

    CAS  PubMed  Google Scholar 

  • Koelsche GA, Prickman LE, Carryer HM (1945) The symptomatic treatment of bronchial asthma and hay fever with benadryl. Proc Staff Meet Mayo Clin 20:432

    CAS  PubMed  Google Scholar 

  • Kollmeier A, Francke K, Chen B, Dunford PJ, Greenspan AJ, Xia Y, Xu XL, Zhou B, Thurmond R (2014) The H4 receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. J Pharmacol Exp Ther 350:181–187

    PubMed  Google Scholar 

  • Krause K, Spohr A, Zuberbier T, Church MK, Maurer M (2013) Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 68:921–928

    PubMed Central  CAS  PubMed  Google Scholar 

  • Kreutner W, Hey JA, Anthes J, Barnett A, Young S, Tozzi S (2000) Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist: receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittelforschung 50:345–352

    CAS  PubMed  Google Scholar 

  • Krogstad AL, Lonnroth P, Larson G, Wallin BG (1997) Increased interstitial histamine concentration in the psoriatic plaque. J Investig Dermatol 109:632–635

    CAS  PubMed  Google Scholar 

  • Kuhne S, Wijtmans M, Lim HD, Leurs R, de Esch IJP (2011) Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? Exp Opin Investig Drugs 20:1629–1648

    CAS  Google Scholar 

  • Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R (2009) Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study. Clin Exp Allergy 39:1338–1347

    CAS  PubMed  Google Scholar 

  • Kupczyk M, Kuprys I, Bochenska-Marciniak M, Gorski P, Kuna P (2007) Ranitidine (150 mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests. Allergy Asthma Proc 28:711–715

    CAS  PubMed  Google Scholar 

  • LaForce CF, Corren J, Wheeler WJ, Berger WE (2004) Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann Allergy Asthma Immunol 93:154–159

    CAS  PubMed  Google Scholar 

  • Lahti A, Haapaniemi T (1993) Initiation of the effects of acrivastine and cetirizine on histamine-induced wheals and itch in human skin. Acta Derm Venereol 73:350–351

    CAS  PubMed  Google Scholar 

  • Lanier BQ, Finegold I, D'Arienzo P, Granet D, Epstein AB, Ledgerwood GL (2004) Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model. Curr Med Res Opin 20:1227–1233

    CAS  PubMed  Google Scholar 

  • Leknes SG, Bantick S, Willis CM, Wilkinson JD, Wise RG, Tracey I (2007) Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. J Neurophysiol 97:415–422

    PubMed  Google Scholar 

  • Leurs R, Smit MJ, Menge WM, Timmerman H (1994a) Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol 112:847–854

    PubMed Central  CAS  PubMed  Google Scholar 

  • Leurs R, Smit MJ, Tensen CP, Ter Laak AM, Timmerman H (1994b) Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H1-receptor agonists. Biochem Biophys Res Commun 201:295–301

    CAS  PubMed  Google Scholar 

  • Leurs R, Tulp MTM, Menge WMBP, Adolfs MJP, Zuiderveld OP, Timmerman H (1995) Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br J Pharmacol 116:2315–2321

    PubMed Central  CAS  PubMed  Google Scholar 

  • Levander S, Haegermark O, Staahle M (1985) Peripheral antihistamine and central sedative effects of three H1-receptor antagonists. Eur J Clin Pharmacol 28:523–529

    CAS  PubMed  Google Scholar 

  • Levander S, Staahle-Baeckdahl M, Haegermark O (1991) Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine. Eur J Clin Pharmacol 41:435–439

    CAS  PubMed  Google Scholar 

  • Lewis T (1927) The blood vessels of the human skin and their responses. Shaw and Sons, London

    Google Scholar 

  • Lewis T (1942) Pain. The Macmillan Company, New York.

    Google Scholar 

  • Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC (2007) BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther 320:365–375

    CAS  PubMed  Google Scholar 

  • Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: Identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314:1310–1321

    CAS  PubMed  Google Scholar 

  • Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, Tenenbaum C, Westfal RE (2000) Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 36:462–468

    CAS  PubMed  Google Scholar 

  • Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC (2008) An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/− mice and patients. Neurobiol Dis 30:74–83

    PubMed  Google Scholar 

  • Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, Fung-Leung W-P (2004) Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 142:161–171

    PubMed Central  CAS  PubMed  Google Scholar 

  • Liu C, Ma X-J, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW (2001a) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420–426

    CAS  PubMed  Google Scholar 

  • Liu C, Wilson SJ, Kuei C, Lovenberg TW (2001b) Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 299:121–130

    CAS  PubMed  Google Scholar 

  • Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG (1999) Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55:1101–1107

    CAS  PubMed  Google Scholar 

  • Lumry W, Prenner B, Corren J, Wheeler W (2007) Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily. Ann Allergy Asthma Immunol 99:267–272

    CAS  PubMed  Google Scholar 

  • Macejko TT, Bergmann MT, Williams JI, Gow JA, Gomes PJ, McNamara TR, Abelson MB (2010) Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0 % and 1.5 % to treat allergic conjunctivitis. Am J Ophthalmol 150:122–127

    CAS  PubMed  Google Scholar 

  • Magerl M, Schmolke J, Siebenhaar F, Zuberbier T, Metz M, Maurer M (2007) Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy (Oxford, UK) 62:1465–1468

    CAS  Google Scholar 

  • Mah FS, Rosenwasser LJ, Townsend WD, Greiner JV, Bensch G (2007) Efficacy and comfort of olopatadine 0.2 % versus epinastine 0.05 % ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge. Curr Med Res Opin 23:1445–1452

    CAS  PubMed  Google Scholar 

  • Marks R, Greaves MW (1977) Vascular reactions to histamine and compound 48/80 in human skin: suppression by a histamine H2-receptor blocking agent. Br J Clin Pharmacol 4:367–369

    PubMed Central  CAS  PubMed  Google Scholar 

  • Matsushita A, Seike M, Okawa H, Kadawaki Y, Ohtsu H (2012) Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis. Exp Dermatol 21:714–715

    CAS  PubMed  Google Scholar 

  • Mela M, Mancuso A, Burroughs AK (2003) Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 17:857–870

    CAS  PubMed  Google Scholar 

  • Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF Jr, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR (2005) Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 95:600–606

    CAS  PubMed  Google Scholar 

  • Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, Garcia-Rafanell J, Forn J (1997) Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 280:114–121

    CAS  PubMed  Google Scholar 

  • Meyer N, Paul C, Misery L (2010) Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat. Acta Derm Venereol 90:12–17

    CAS  PubMed  Google Scholar 

  • Meyrick-Thomas RH, Browne PD, Kirby JDT (1985a) The effect of ranitidine, alone and in combination with clemastine, on allergen-induced cutaneous wheal-and-flare reactions in human skin. J Allergy Clin Immunol 76:864–869

    CAS  PubMed  Google Scholar 

  • Meyrick-Thomas RH, Browne PD, Kirby JDT (1985b) The influence of ranitidine, alone and in combination with clemastine, on histamine-mediated cutaneous weal and flare reactions in human skin. Br J Clin Pharmacol 20:377–382

    CAS  Google Scholar 

  • Miadonna A, Tedeschi A, Leggieri E, Lorini M, Folco G, Sala A, Qualizza R, Froldi M, Zanussi C (1987) Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis 136:357–362

    CAS  PubMed  Google Scholar 

  • Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K (2003) Imaging of central itch modulation in the human brain using positron emission tomography. Pain 105:339–346

    PubMed  Google Scholar 

  • Mochizuki H, Sadato N, Saito DN, Toyoda H, Tashiro M, Okamura N, Yanai K (2007) Neural correlates of perceptual difference between itching and pain: a human fMRI study. Neuroimage 36:706–717

    PubMed  Google Scholar 

  • Mommert S, Gschwandtner M, Koether B, Gutzmer R, Werfel T (2012) Human memory Th17 cells express a functional histamine H4 receptor. Am J Pathol 180:177–185

    CAS  PubMed  Google Scholar 

  • Monroe EW (1992) Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther 14:17–21

    CAS  PubMed  Google Scholar 

  • Monroe E, Finn A, Patel P, Guerrero R, Ratner P, Bernstein D (2003) Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 48:535–541

    PubMed  Google Scholar 

  • Morita E, Matsuo H, Zhang Y (2005) Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: Suppressive effects on skin response to histamine iontophoresis. J Dermatol 32:58–61

    CAS  PubMed  Google Scholar 

  • Morse KL, Behan J, Laz TM, West RE Jr, Greenfeder SA, Anthes JC, Umland S, Wan Y, Hipkin RW, Gonsiorek W, Shin N, Gustafson EL, Qiao X, Wang S, Hedrick JA, Greene J, Bayne M, Monsma FJ Jr (2001) Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296:1058–1066

    CAS  PubMed  Google Scholar 

  • Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B (2002) Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc 23:391–398

    CAS  PubMed  Google Scholar 

  • Mygind N (1982) Mediators of nasal allergy. J Allergy Clin Immunol 70:149–159

    CAS  PubMed  Google Scholar 

  • Mygind N, Secher C, Kirkegaard J (1983) Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl 128(Pt 1):16–20

    PubMed  Google Scholar 

  • Naclerio RM, Togias AG (1991) The nasal allergic reaction: observations on the role of histamine. Clin Exp Allergy 21(Suppl 2):13–19

    PubMed  Google Scholar 

  • Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K (2000) Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 279:615–620

    CAS  PubMed  Google Scholar 

  • Nakano Y, Takahashi Y, Ono R, Kurata Y, Kagawa Y, Kamei C (2009) Role of histamine H4 receptor in allergic conjunctivitis in mice. Eur J Pharmacol 608:71–75

    CAS  PubMed  Google Scholar 

  • Namdar R, Valdez C (2011) Alcaftadine: a topical antihistamine for use in allergic conjunctivitis. Drugs Today 47:883–890

    CAS  PubMed  Google Scholar 

  • Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP (1983) Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 71:177–183

    CAS  PubMed  Google Scholar 

  • Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A (2006) Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol 154:533–538

    CAS  PubMed  Google Scholar 

  • Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF (2001) Discovery of a novel member of the histamine receptor family. Mol Pharmacol 59:427–433

    CAS  PubMed  Google Scholar 

  • Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B (2003) The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial. Clin Exp Allergy 33:351–358

    CAS  PubMed  Google Scholar 

  • O’Leary PA, Farber EM (1945) Benadryl in the treatment of urticaria. Proc Staff Meet Mayo Clin 20:429–432

    PubMed  Google Scholar 

  • Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275:36781–36786

    CAS  PubMed  Google Scholar 

  • O'Donnell N, Dunford PJ, Thurmond RL (2006) The histamine H4 receptor: drug discovery in the post-genomic era. In: Falus A (ed) Immunogenomics and human disease. Wiley, West Sussex, England, pp 395–406

    Google Scholar 

  • Oei HD (1988) Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Annals Allergy 61:436–439

    CAS  Google Scholar 

  • Ohsawa Y, Hirasawa N (2012) The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy 67:1014–1022

    CAS  PubMed  Google Scholar 

  • O'Reilly M, Alpert R, Jenkinson S, Gladue RP, Foo S, Trim S, Peter B, Trevethick M, Fidock M (2002) Identification of a histamine H4 receptor on human eosinophils-role in eosinophil chemotaxis. J Recept Signal Transduct 22:431–448

    Google Scholar 

  • Orfeo V, Vardaro A, Lena P, Mensitieri I, Tracey M, De Marco R (2002) Comparison of emedastine 0.05 % or nedocromil sodium 2 % eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis. Eur J Ophthalmol 12:262–266

    CAS  PubMed  Google Scholar 

  • Ortonne JP (2011) Chronic urticaria: a comparison of management guidelines. Expert Opin Pharmacother 12:2683–2693

    CAS  PubMed  Google Scholar 

  • Ortonne JP, Grob JJ, Auquier P, Dreyfus I (2007) Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol 8:37–42

    PubMed  Google Scholar 

  • Panula P, Nuutinen S (2013) The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 14:472–487

    CAS  PubMed  Google Scholar 

  • Papoiu ADP, Coghill RC, Kraft RA, Wang H, Yosipovitch G (2012) A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. Neuroimage 59:3611–3623

    PubMed Central  PubMed  Google Scholar 

  • Parrot J-J (1942) Les modifications aportees par un antagoniste de l'histamine (2,339 R.P.) a la reaction vasculaire locale de la peau. CR Seances Soc Biol Ses Fil 136:715–716

    CAS  Google Scholar 

  • Potter PC (2003) Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 58:893–899

    CAS  PubMed  Google Scholar 

  • Pour-Reza-Gholi F, Nasrollahi A, Firouzan A, Nasli Esfahani E, Farrokhi F (2007) Low-dose doxepin for treatment of pruritus in patients on hemodialysis. Iran J Kidney Dis 1:34–37

    PubMed  Google Scholar 

  • Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, Mirakian R, Walker SM, Huber PA, Nasser SM (2007) BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 37:631–650

    CAS  PubMed  Google Scholar 

  • Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R (2007) Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity. J Pharmacol Exp Ther 321:975–982

    CAS  PubMed  Google Scholar 

  • Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES (1994) Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am J Respir Crit Care Med 149:1506–1511

    CAS  PubMed  Google Scholar 

  • Ratner PH, Hampel FC, Amar NJ, van Bavel JH, Mohar D, Marple BF, Roland PS, Wall GM, Brubaker MJ, Drake M, Turner D, Silver LH (2005) Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol 95:474–479

    CAS  PubMed  Google Scholar 

  • Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H (2008) Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 100:74–81

    CAS  PubMed  Google Scholar 

  • Reunala T, Brummer-Korvenkontio H, Karppinen A, Coulie P, Palosuo T (1993) Treatment of mosquito bites with cetirizine. Clin Exp Allergy 23:72–75

    CAS  PubMed  Google Scholar 

  • Roberson DP, Gudes S, Sprague JM, Patoski HAW, Robson VK, Blasl F, Duan B, Oh SB, Bean BP, Ma Q, Binshtok AM, Woolf CJ (2013) Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons. Nat Neurosci 16:910–918

    CAS  PubMed  Google Scholar 

  • Rossbach K, Wendorff S, Sander K, Stark H, Gutzmer R, Werfel T, Kietzmann M, Baeumer W (2009) Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18:57–63

    CAS  PubMed  Google Scholar 

  • Rossbach K, Nassenstein C, Gschwandtner M, Schnell D, Sander K, Seifert R, Stark H, Kietzmann M, Baeumer W (2011) Histamine H1, H3 and H4 receptors are involved in pruritus. Neuroscience 190:89–102

    CAS  PubMed  Google Scholar 

  • Rukwied R, Lischetzki G, McGlone F, Heyer G, Schmelz M (2000) Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients. A dermal microdialysis study. Br J Dermatol 142:1114–1120

    CAS  PubMed  Google Scholar 

  • Russo GE, Spaziani M, Guidotti C, Scarpellini MG, Leri O, Bonini S, Crisciotti C, Carmenini G (1986) Pruritus in chronic uremic patients in periodic hemodialysis. Treatment with terfenadine (an antagonist of histamine H1 receptors). Minerva Urol Nefrol 38:443–447

    CAS  PubMed  Google Scholar 

  • Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K (2009) Guidelines for management of atopic dermatitis. J Dermatol 36:563–577

    PubMed  Google Scholar 

  • Saitoh T, Fukushima Y, Otsuka H, Ishikawa M, Tamai M, Takahashi H, Mori H, Asano T, Anai M, Ishikawa T, Katsube T, Ogawa K, Kajiwara T, Omata M, Ohkawa S (2002) Effects of N-alpha-methyl-histamine on human H2 receptors expressed in CHO cells. Gut 50:786–789

    PubMed Central  CAS  PubMed  Google Scholar 

  • Schmelz M (2001) A neural pathway for itch. Nat Neurosci 4:9–10

    CAS  PubMed  Google Scholar 

  • Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE (1997) Specific C-receptors for Itch in human skin. J Neurosci 17:8003–8008

    CAS  PubMed  Google Scholar 

  • Schmelz M, Schmidt R, Weidner C, Hilliges M, Torebjoerk HE, Handwerker HO (2003) Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 89:2441–2448

    CAS  PubMed  Google Scholar 

  • Schneider G, Staender S, Burgmer M, Driesch G, Heuft G, Weckesser M (2008) Significant differences in central imaging of histamine-induced itch between atopic dermatitis and healthy subjects. Eur J Pain (Amsterdam, Netherland) 12:834–841

    CAS  Google Scholar 

  • Schwartz JC (2009) Preclinical and clinical pharmacology of H3 receptor inverse agonist. In: 22nd ECNP congress p S.19.02, Istanbul, Turkey

    Google Scholar 

  • Secher C, Kirkegaard J, Borum P, Maansson A, Osterhammel P, Mygind N (1982) Significance of H1 and H2 receptors in the human nose: rationale for topical use of combined antihistamine preparations. J Allergy Clin Immunol 70:211–218

    CAS  PubMed  Google Scholar 

  • Seifert R, Wenzel-Seifert K, Burckstummer T, Pertz HH, Schunack W, Dove S, Buschauer A, Elz S (2003) Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor. J Pharmacol Exp Ther 305:1104–1115

    CAS  PubMed  Google Scholar 

  • Seike M, Furuya K (2007) Thioperamide (H3 and H4 receptor antagonist) improves ecezematous lesions in murine contact dermatitis. Sagami Joshi Daigaku Kiyo, Shizenkei 71B:7–13

    CAS  Google Scholar 

  • Seike M, Furuya K, Omura M, Hamada-Watanabe K, Matsushita A, Ohtsu H (2010) Histamine H4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy 65:319–326

    CAS  PubMed  Google Scholar 

  • Sharif NA, Xu SX, Yanni JM (1996) Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long-acting, H1-selective histamine antagonist and antiallergic agent for use in allergic conjunctivitis. J Ocul Pharmacol Ther 12:401–407

    CAS  PubMed  Google Scholar 

  • Shelley WB, Melton FM (1950) Relative effect of local anesthetics on experimental histamine pruritus in man. J Investig Dermatol 15:299–300

    CAS  PubMed  Google Scholar 

  • Shelton D, Eiser N (1994) Histamine receptors in the human nose. Clin Otolaryngol Allied Sci 19:45–49

    CAS  PubMed  Google Scholar 

  • Shim W-S, Tak M-H, Lee M-H, Kim M, Kim M, Koo J-Y, Lee C-H, Kim M, Oh U (2007) TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 27:2331–2337

    CAS  PubMed  Google Scholar 

  • Shin N, Covington M, Bian D, Zhuo J, Bowman K, Li Y, Soloviev M, Qian D-Q, Feldman P, Leffet L, He X, Wang KH, Krug K, Bell D, Czerniak P, Hu Z, Zhao H, Zhang J, Yeleswaram S, Yao W, Newton R, Scherle P (2012) INCB38579, a novel and potent histamine H4 receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions. Eur J Pharmacol 675:47–56

    CAS  PubMed  Google Scholar 

  • Shiraishi Y, Jia Y, Domenico J, Joetham A, Karasuyama H, Takeda K, Gelfand EW (2013) Sequential engagement of FcÎμRI on mast cells and basophil histamine H4 receptor and FceRI in allergic rhinitis. J Immunol 190:539–548

    PubMed Central  CAS  PubMed  Google Scholar 

  • Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M (2009) High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 123:672–679

    CAS  PubMed  Google Scholar 

  • Simone DA, Zhang X, Li J, Zhang J-M, Honda CN, LaMotte RH, Giesler GJ Jr (2004) Comparison of responses of primate spinothalamic tract neurons to pruritic and algogenic stimuli. J Neurophysiol 91:213–222

    PubMed  Google Scholar 

  • Simpson RJ (1994) Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Annals Allergy 73:497–502

    CAS  Google Scholar 

  • Sollmann T, Pilcher JD (1917) Endermic reactions. I. J Pharmacol 9:309–340

    CAS  Google Scholar 

  • Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117:411–417

    CAS  PubMed  Google Scholar 

  • Spangler DL, Bensch G, Berdy GJ (2001) Evaluation of the efficacy of olopatadine hydrochloride 0.1 % ophthalmic solution and azelastine hydrochloride 0.05 % ophthalmic solution in the conjunctival allergen challenge model. Clin Ther 23:1272–1280

    CAS  PubMed  Google Scholar 

  • Spangler DL, Abelson MB, Ober A, Gotnes PJ (2003) Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clin Ther 25:2245–2267

    CAS  PubMed  Google Scholar 

  • Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, Church DS, Dimitrov V, Church MK (2010) The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 125:676–682

    CAS  PubMed  Google Scholar 

  • Staub AM, Bovet D (1937) Action of thymoxyethyldiethylamine (F 929) and other phenol ethers on anaphylactic shock in guinea pigs. C R Seances Soc Biol Fil 125:818–821

    CAS  Google Scholar 

  • Stokes JR, Romero FA Jr, Allan RJ, Phillips PG, Hackman F, Misfeldt J, Casale TB (2012) The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms. J Allergy Clin Immunol 129:409–412.e402

    CAS  PubMed  Google Scholar 

  • Storms WW, Bodman SF, Nathan RA, Chervinsky P, Banov CH, Dockhorn RJ, Jarmoszuk I, Zeitz HJ, McGeady SJ, Pinnas JL et al (1989) SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis. J Allergy Clin Immunol 83:1083–1090

    CAS  PubMed  Google Scholar 

  • Strakhova MI, Nikkel AL, Manelli AM, Hsieh GC, Esbenshade TA, Brioni JD, Bitner RS (2009) Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res 1250:41–48

    CAS  PubMed  Google Scholar 

  • Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong GSC, Krueger JG, Guttman-Yassky E (2013) Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 132:361–370

    Google Scholar 

  • Sugimoto Y, Iba Y, Nakamura Y, Kayasuga R, Kamei C (2004) Pruritus-associated response mediated by cutaneous histamine H3 receptors. Clin Exp Allergy 34:456–459

    CAS  PubMed  Google Scholar 

  • Suwa E, Yamaura K, Oda M, Namiki T, Ueno K (2011) Histamine H4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. Eur J Pharmacol 667:383–388

    CAS  PubMed  Google Scholar 

  • Takahashi Y, Kagawa Y, Izawa K, Ono R, Akagi M, Kamei C (2009) Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int Immunopharmacol 9:734–738

    CAS  PubMed  Google Scholar 

  • Tamura T, Matsubara M, Amano T, Chida M (2008) Olopatadine ameliorates rat experimental cutaneous inflammation by improving skin barrier function. Pharmacology 81:118–126

    CAS  PubMed  Google Scholar 

  • Tanizaki H, Ikoma A, Fukuoka M, Miyachi Y, Kabashima K (2012) Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch. Int Arch Allergy Immunol 158:191–195

    CAS  PubMed  Google Scholar 

  • Tanizaki H, Nakahigashi K, Miyachi Y, Kabashima K (2013a) Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations. J Dermatolog Treat 24:477–480

    CAS  PubMed  Google Scholar 

  • Tanizaki H, Nakamizo S, Nakahigashi K, Miyachi Y, Kabashima K (2013b) A Double Dose of Levocetirizine Leads to Better Control of Histamine-Induced Flare, Wheal and Itch in Healthy Donors. Pharmacology 92:71–74

    CAS  PubMed  Google Scholar 

  • Taylor-Clark T, Sodha R, Warner B, Foreman J (2005) Histamine receptors that influence blockage of the normal human nasal airway. Br J Pharmacol 144:867–874

    PubMed Central  CAS  PubMed  Google Scholar 

  • Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung W-P, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309:404–413

    CAS  PubMed  Google Scholar 

  • Tokura Y (2010) Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 58:1–7

    CAS  PubMed  Google Scholar 

  • Torkildsen G, Shedden A (2011) The safety and efficacy of alcaftadine 0.25 % ophthalmic solution for the prevention of itching associated with allergic conjunctivitis. Curr Med Res Opin 27:623–631

    CAS  PubMed  Google Scholar 

  • Tran VT, Chang RS, Snyder SH (1978) Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. Proc Natl Acad Sci U S A 75:6290–6294

    PubMed Central  CAS  PubMed  Google Scholar 

  • Trendelenburg U, Hobbs RD (1960) Action of histamine and 5-hydroxytryptamine (5-HT) on isolated mammalian atria. J Pharmacol Exp Ther 130:450–460

    CAS  PubMed  Google Scholar 

  • Varga C, Horvath K, Berko A, Thurmond RL, Dunford PJ, Whittle BJR (2005) Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur J Pharmacol 522:130–138

    CAS  PubMed  Google Scholar 

  • Wang DY, Hanotte F, De VC, Clement P (2001) Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers. Allergy (Copenhagen) 56:339–343

    CAS  Google Scholar 

  • Wang YH, Tache Y, Harris AG, Kreutner W, Daly AF, Wei JY (2005) Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique. Allergy (Oxford, UK) 60:117–124

    CAS  Google Scholar 

  • Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C (2012) Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. CNS Drugs 26:421–434

    CAS  PubMed  Google Scholar 

  • Weisshaar E, Ziethen B, Gollnick H (1997) Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm Res 46:412–416

    CAS  PubMed  Google Scholar 

  • Wellendorph P, Goodman MW, Burstein ES, Nash NR, Brann MR, Weiner DM (2002) Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor. Neuropharmacology 42:929–940

    CAS  PubMed  Google Scholar 

  • Weller K, Maurer M (2009) Desloratadine inhibits human skin mast cell activation and histamine release. J Investig Dermatol 129:2723–2726

    CAS  PubMed  Google Scholar 

  • Whitcup SM, Bradford R, Lue J, Schiffman RM, Abelson MB (2004) Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. Clin Ther 26:29–34

    CAS  PubMed  Google Scholar 

  • Wieland K, Bongers G, Yamamoto Y, Hashimoto T, Yamatodani A, Menge WMBP, Timmerman H, Lovenberg TW, Leurs R (2001) Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists. J Pharmacol Exp Ther 299:908–914

    CAS  PubMed  Google Scholar 

  • Wiesner RH, LaRusso NF, Ludwig J, Dickson ER (1985) Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 88:108–114

    CAS  PubMed  Google Scholar 

  • Williams HC (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352:2314–2324

    CAS  PubMed  Google Scholar 

  • Wilson AM, Haggart K, Sims EJ, Lipworth BJ (2002) Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy 32:1504–1509

    CAS  PubMed  Google Scholar 

  • Windaus A, Vogt W (1907) Synthese des imidazolyl-athylamins. Ber Dtsch Chem Ges 40:3691–3695

    Google Scholar 

  • Wood-Baker R, Lau L, Howarth PH (1996) Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism. Clin Otolaryngol Allied Sci 21:348–352

    CAS  PubMed  Google Scholar 

  • Wulff BS, Hastrup S, Rimvall K (2002) Characteristics of recombinantly expressed rat and human histamine H3 receptors. Eur J Pharmacol 453:33–41

    CAS  PubMed  Google Scholar 

  • Wyllie JH, Hesselbo T, Black JW (1972) Effects in man of histamine H2-receptor blockade by burimamide. Lancet 2:1117–1120

    CAS  PubMed  Google Scholar 

  • Yamaura K, Oda M, Suwa E, Suzuki M, Sato H, Ueno K (2009) Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J Toxicol Sci 34:427–431

    CAS  PubMed  Google Scholar 

  • Yaylali V, Demirlenk I, Tatlipinar S, Ozbay D, Esme A, Yildirim C, Ozden S (2003) Comparative study of 0.1 % olopatadine hydrochloride and 0.5 % ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta Ophthalmol Scand 81:378–382

    CAS  PubMed  Google Scholar 

  • Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL (2000) The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 143:969–973

    CAS  PubMed  Google Scholar 

  • Yosipovitch G, Fast K, Bernhard JD (2005) Noxious heat and scratching decrease histamine-induced itch and skin blood flow. J Investig Dermatol 125:1268–1272

    CAS  PubMed  Google Scholar 

  • Yosipovitch G, Duque MI, Fast K, Dawn AG, Coghill RC (2007) Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study. Br J Dermatol 156:629–634

    CAS  PubMed  Google Scholar 

  • Yu F, Wolin RL, Wei J, Desai PJ, McGovern PM, Dunford PJ, Karlsson L, Thurmond RL (2010) Pharmacological characterization of oxime agonists of the histamine H4 receptor. J Recept Ligand Channel Res 3:37–49

    CAS  Google Scholar 

  • Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, Boyce R, Alston J, Tierney LA, Li X, Herrity NC, Vawter L, Sarau HM, Ames RS, Davenport CM, Hieble JP, Wilson S, Bergsma DJ, Fitzgerald LR (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59:434–441

    CAS  PubMed  Google Scholar 

  • Zonneveld IM, Meinardi MM, Karlsmark T, Johansen UB, Kuiters GR, Hamminga L, Staberg B, van't Veen AJ, Bossuyt PM, van Niel JC, Bos JD (1997) Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study. J Am Acad Dermatol 36:932–934

    CAS  PubMed  Google Scholar 

  • Zuber P, Pecoud A (1988) Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens. J Allergy Clin Immunol 82:590–594

    CAS  PubMed  Google Scholar 

  • Zuberbier T (2012) Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses. J Eur Acad Dermatol Venereol 26:9–18

    CAS  PubMed  Google Scholar 

  • Zuberbier T, Maurer M (2007) Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 87:196–205

    PubMed  Google Scholar 

  • Zuberbier T, Maurer M (2010) Antihistamines in the treatment of urticaria. Adv Exp Med Biol 709:67–72

    CAS  PubMed  Google Scholar 

  • Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B (2009) EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 64:1427–1443

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robin L. Thurmond .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thurmond, R.L., Kazerouni, K., Chaplan, S.R., Greenspan, A.J. (2015). Antihistamines and Itch. In: Cowan, A., Yosipovitch, G. (eds) Pharmacology of Itch. Handbook of Experimental Pharmacology, vol 226. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44605-8_15

Download citation

Publish with us

Policies and ethics